BELAMI: A Multicenter Study of Belantamab Mafodotin and Mezigdomide in Patients With Relapsed Multiple Myeloma (clinicaltrials.gov) - Oct 10, 2026 - P1/2 | N=44 | Not yet recruiting | Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Initiation date: Jun 2026 ➔ Dec 2026
Trial initiation date • Hematological Malignancies • Multiple Myeloma • Oncology
|